Contributors and references

This pre-core test indicator and its threshold values are yet to be commonly agreed in HELCOM and the presented thresholds are furthermore not currently approved EQS values, but provisional proposals.
The indictor is included as a test indicator for the purposes of the 'State of the Baltic Sea' report, and the results are to be considered as intermediate.

Contributors

Ekaterina Chernova, Lena Avellan, Kari Lehtonen, Jakob Strand, Dmitry Frank-Kamenetsky, Owen Rowe

The HELCOM Correspondence Group on Pharmaceuticals (HELCOM GC PHARMA) has also contributed and reviewed this document.

 

Archive

This version of the HELCOM indicator report was published in July 2018:

Diclofenac HELCOM pre-core indicator 2018 (pdf)

There are no previous versions of this indicator report at present.

 

References

Andersson, J., Woldegiorgis, A., Remberger, M., Kaj, L., Ekheden, Y., Dusan, B., Svenson, A., Brorström-Lunden, E., Dye, C & Schlabach, N. (2006). Results from the Swedish national screening programme. Subreport 1: Anti-biotics, anti-inflammatory substances and hormones. Swedish Environment Research Institute. IVL Report B1689.

Atlasi Daneshvar, Jesper Svanfelt, Leif Kronberg, Gesa A. Weyhenmeyer. (2012). Neglected sources of pharmaceuticals in river water—footprints of a Reggae festival. J Environ Monit 14(2): 596-603. doi: 10.1039/c1em10551e

Baranauskaitė, I. and Dvarionienė, J. (2014). Presence and detection of pharmaceutical substances (Diclofenac, 17-β-estradiol, 17-α-etilinestradiol) in the environment. Future challenges for Lithuania. Environmental Research, Engineering and Management 2(68): 25-40.

Bendz, D.; Paxeus, N.A.; Ginn, T.R.; Loge, F.J. (2005). Occurrence and fate of pharmaceutically active compounds in the environment, a case study: Hoje River in Sweden. Journal of Hazardous Materials, Volume 122, Issue 3, July 2005, Pages 195-204.

Borecka, M., Siedlewicz, G., Haliński, L. P., Sikora, K & Pazdro, K. (2015). Contamination of the southern Baltic Sea by the residues of selected pharmaceuticals: Method development and field studies. Marine Pollution Bulletin. 94: 62-71.

Breitholtz, M., Näslund, M., Stråe, D., Borg, H., et al., (2012). An evaluation of free water surface wetlands as tertiary sewage water treatment of micro-pollutants. Ecotoxicology and Environmental Safety 78: 63-71.

Brown JN, Paxéus N, Förlin L, Larsson DGJ. (2007). Variations in bioconcentration of human pharmaceuticals from sewage effluents into fish blood plasma. Environmental Toxicology and Pharmacology; 24: 267-274.

Brozinski, J-M., Lahti, M., Meierjohann, A., Oikari, A. & Kronberg, L. (2013). The anti-inflammatory drugs diclofenac, naproxen and ibuprofen are found in the bile of wild fish caught down-stream of a wastewater treatment plant. Environmental Science and Technology. 47: 342-8.

Cleuvers, M. (2004). Mixture toxicity of the anti-inflammatory drugs diclofenac, ibuprofen, naproxen, and acetylsalicylic acid. Ecotoxicology and environmental safety 59(3): 309-315.

Cuklev, F., Kristiansson, E., Fick, J., Asker, N., Förlin, L., & Larsson D. G. J. (2011). Diclofenac in fish: blood plasma levels similar to human therapeutic levels affect global hepatic gene expression. Environmental Toxicology and Chemistry 30 (9): 2126-2134.

Cuthbert, R., Parry-Jones, J., Green, R.E. & Pain, D.J. (2006). NSAIDS and scavenging birds: Potential impacts beyond Asia's critically endangered vultures. Biology Letters, 22, 90–93

Cuthbert R, Parry-Jones J, Green RE, Pain DJ. (2007). NSAIDs and scavenging birds: Potential impacts beyond Asia's critically endangered vultures. Biol Lett 3:90–93. 

Dossier Diclofenac_Draft_JRC-2017_V4.1-GM(update 31-05-2017)_JRC 25June2017 as viewed on 13.11.17 at: https://circabc.europa.eu/w/browse/412c0e12-6235-497f-8607-2d8dc1d95da7.

Eades, C., Waring, C.P. (2010). The effects of diclofenac on the physiology of the green shore crab Carcinus maenas. Marine Environmental Research 69:46–48.

European Commission (2013). Directive 2013/39/EU of the European Parliament and of the Council of 12 August 2013 amending Directives 2000/60/EC and 2008/105/EC as regards priority substances in the field of water policy. Off. J. Eur. Union L 226: 1-17.

European Commission (2015). Commision Implementing Decission 2015/495/EU establishing a watch list of substances for Union-wide monitoring in the field of water policy pursuant to Directive 2008/105/EC of the European Parliament and of the Council.

Fick, J., Lindberg, RH., Kaj, L. & Brorström-Lundén, E. (2011). Results from the Swedish national screening programme 2010. Subreport 3: Pharmaceuticals. Swedish Environment Research Institute. IVL Report B2014.

Fick et al 2015. Screening 2014: Analysis of pharmaceuticals and hormones in samples from WWTPs and receiving waters: http://urn.kb.se/resolve?urn=urn:nbn:se:naturvardsverket:diva-6505.

Gonzalez-Rey, M., & Bebianno, M. J. (2014). Effects of non-steroidal anti-inflammatory drug (NSAID) diclofenac exposure in mussel Mytilus galloprovincialis. Aquatic toxicology: 148, 221-230.

Haglund, P. and Olofsson, U. (2011). Miljöövervakning av utgående vatten & slam från svenska avloppsreningsverk. Resultat från år 2010 och en sammanfattning av slamresultaten för åren 2004-2010. Kemiska institutionen vid Umeå universitet på uppdrag av Naturvårdsverket.

Haglund, P. and Olofsson, U. (2013). Miljöövervakning av utgående vatten & slam från svenska avloppsreningsverk. Resultat från år 2011 och en sammanfattning av slamresultaten för åren 2004‐2011. Kemiska institutionen vid Umeå universitet på uppdrag av Naturvårdsverket.

Haglund, P. and Olofsson, U. (2014). Miljöövervakning av utgående vatten & slam från svenska avloppsreningsverk. Resultat från år 2012 och 2013 och en sammanfattning av slamresultaten för åren 2004-2013. Kemiska institutionen vid Umeå universitet på uppdrag av Naturvårdsverket.

Haglund 2015. http://urn.kb.se/resolve?urn=urn:nbn:se:naturvardsverket:diva-6909.

Hallare, A. V., Köhler, H-R. & Triebskorn, R. (2004). Developmental toxicity and stress protein response in zebrafish embryos after exposure to diclofenac and its solvent, DMSO. Chemosphere 56; 659-66.

Hallgren, P. & Wallberg, P. (2015). Background report on pharmaceutical concentrations and effects in the Baltic Sea. Policy Area Hazards of the EU Strategy for the Baltic Sea Region. Swedish Environmental Protection Agency, Stockholm, Sweden.

HELCOM (2014) BASE project 2012-2014: Pilot activity to identify sources and flow patterns of pharmaceuticals in St. Petersburg to the Baltic Sea.

Hoeger, B., Köllnere, B., Dietrich, D.R., & Hitzfeld, B. (2005). Water-borne diclofenac affects kidney and gill integrity and selected immune parameters in brown trout (Salmo trutta f. fario). Aquatic Toxicology 75: 53-64.

Kallio, J-M., Lahti, M., Oikari, A. & Kronberg, L. (2010). Metabolites of the aquatic pollutant diclofenac in fish bile. Environmental Science and Technology 44: 7213-7219.

Karlsson, M. & Viktor, T. (2014). Miljöstörande ämnen I fisk från Stockholmsregionen 2013. Raport B2214 from the Swedish Environment Research Institute IVL.

Kavander K., 2017. Lääkeaineiden kulkeutuminen ja poistuminen urbaanin hydrologisen kierron aikana. Master's thesis, Tampere University of Technology.

Kraigher, B., Kesjek, T., Heath, E., Kompare, B., & Mandic-Mulec, I. (2008). Influence of pharmaceutical residues on the structure of activated sludge bacterial communities in wastewater treatment bioreactors. Water Research 42: 4578-88.

Kumblad, L., Oskarsson, H., Palmer, C., & Wiklund, A. K. E. (2015). Response and recovery of Baltic Sea blue mussels from exposure to pharmaceuticals. Marine Ecology Progress Series, 526: 89-100.

Lehtonen, K.K., Sundelin, B., Lang T., & Strand, J. (2014). Development of tools for integrated monitoring and assessment of hazardous substances and their biological effects in the Baltic Sea. AMBIO 42: 69-81.

Lember, E., Pachel, K., & Loigu, E. (2016). Modelling diclofenac and ibuprofen residues in major Estonian seaside cities. Journal of Water Security 2.

Lilja, K., Remberger, M., Kaj, L., Allard, A.-S., Andersson, H. & Brorström-Lunden, E. (2010). Chemical and biological monitoring of sewage effluent water. Swedish Environment Research Institute. IVL Report B1897.

Lindholm-Lehto P. 2016. Occurence of Pharmaceuticals in Municipal Wastewater Treatment Plants and Receiving Surface Waters in Central and Southern Finland. Dissertation. Department of Chemistry, University of Jyväskylä, Research report No. 194

Lindholm-Lehto P.C., Ahkola H.S.J., Knuutinen J.S., Koistinen J., Lahti K., Vahtera H., Herve S.H. (2016). Suitability of passive sampling for the monitoring of pharmaceuticals in Finnish Surface waters. Environmental Science and Pollution Research, 18:18043-18054.

Lindim, C., van Gils, J., Georgieva, D., Mekenyan, O., & Cousins, I.T. (2016). Evaluation of human pharmaceutical emissions and concentrations in Swedish river basins. Science of the Total Environment. 572: 508-519.

Lindim, C., van Gils, J., Cousins, I.T., Kuhne, R., Georgieva, D., & Kutsarova, S. (2017). Model-predicted occurrence of multiple pharmaceuticals in Swedish surface waters and their flushing to the Baltic Sea. Environmental Pollution 223: 595-604.

Lindqvist N., Tuhkanen T., Kronberg L. 2005. Occurence of acidic pharmaceuticals in raw and treated sewages and in receiving waters. Water research 39 (2005): 2219 - 2228.

Lonappan, L., Brar, S.K., Das, R.K., Verma, M. & Surampalli, R.Y. (2016). Diclofenac and its transformation products: Environmental occurrence and tioxicity – A review. Environment International 96: 127-138.

Löf, M., Sundelin, B., Liewenborg, B., Bandh, C., Broeg, K., et al., (2016). Biomarker-enhanced assessment of reproductive disorders in Monoporeia affinis exposed to contaminated sediment in the Baltic Sea. Ecological Indicators: 63, 187-195.

Mezzelani, M., Gorbi, S., Da Ros, Z., Fattorini, D., d'Errico, et al., (2016). Ecotoxicological potential of non-steroidal anti-inflammatory drugs (NSAIDs) in marine organisms: bioavailability, biomarkers and natural occurrence in Mytilus galloprovincialis. Marine environmental research121, 31-39.

Miljøministeriet, Naturstyrelsen (2015). NOVANA-Screeningsundersøgelse for humane lægemidler i vandmiljøet (In Danish). Available at: http://naturstyrelsen.dk/media/133385/screening-for-humane-laegemilder-i-vandmiljoeet.pdf

Munari, M., Chemello, G., Finos, L., Ingrosso, G., Giani, M., & Marin, M. G. (2016). Coping with seawater acidification and the emerging contaminant diclofenac at the larval stage: A tale from the clam Ruditapes philippinarum. Chemosphere: 160, 293-302.

Muter, O; , I; Svinka, V; Svinka, R; and Bartkevics, V. (2017) Distinguishing the roles of carrier and biofilm in filtering media for the removal of pharmaceutical compounds from wastewater. Process Safety and Environmental Protection (111) 462-474.

Oaks JL, Gilbert M, Virani MZ, Watson RT, Meteyer CU, et al. (2004). Diclofenac residues as the cause of vulture population declines in Pakistan. Nature 427: 630–633.

Perez, S., Barcelo, D. (2008). First evidence for occurrence of hydroxylated human metabolites  of diclofenac and aceclofenac in wastewater using  QqLIT-MS and QqTOF-MS. Anal. Chem. 80, 8135-8145.

Quintama, J.B. & Reemtsma, T. (2004). Sensitive determination of acidic drugs and triclosan in surface and wastewater by ion-pair reverse-phase liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom. 18:765–774.

Reddy NCP, Anjaneyulu Y., Sivasankari, B & Rao KA. (2006). Comparative toxicity studies in birds using nimesulide and diclofenac sodium. Environmental Toxicology and Pharmacology, 22, 142–147.

Reinholds, I., Pugajeva, I., Zacs, D. et al. Environ Monit Assess (2017) 189: 568. https://doi.org/10.1007/s10661-017-6304-9

Remberger, M., Wiklund, P., Woldegiorgis, A., Viktor, T., Kaj, l. & Brorström-Lundén, E. (2009). Anti-inflammatory and analgesic drugs in WWTP influent and effluent streams and the occurrence in the aquatic environment. Swedish Environmental Research Institute. IVL Report B1810.

Schmidt, W., O'Rouke, K., Hernan, R. & Quinn, B. (2011). Effects of the pharmaceuticals gemfibrozil and diclofenac on the marine mussel (Mytilus spp.) and their comparison with standard toxicity tests. Marine Pollution Bulletin 62: 1389-1395.

Schmidt, W., Rainville, L-C., McEneff, G., Sheehan, D. & Quinn, B. (2013). A proteomic evaluation of the effects of the pharmaceuticals diclofenac and gemfibrozil on marine mussels (Mytilus spp.): evidence for chronic sublethal effects on stress-response proteins. Drug Testing and Analysis 6: 210-219.

Schmitt-Jansen, M., Bartels, P., Adler, N., & Altenburger, R. (2007). Phytotoxicity assessment of diclofenac and its phototransformation products. Analytical and bioanalytical chemistry 387(4): 1389-1396.

Schwaiger J; Ferling H; Mallow U; Wintermayr H; Negele RD. (2004). Toxic effects of the non-steroidal anti-inflammatory drug diclofenac. Part I: histopathological alterations and bioaccumulation in rainbow trout. Aquatic Toxicology 68: 141–150.

Shultz, S., Baral, H.S., Sheonaidh, C., Cunningham, A.A., Devojit, D., Ghalsasi, G.R., Goudar, M.S., Green, R.E., Jones, A., Prashant, N., Pain, D.J., Vibhu, P., (2004). Diclofenac poisoning is widespread in declining vulture populations across the Indian subcontinent. Proc. R. Soc. Lond. B Biol. Sci. 271, S458–S460.

Schwaiger, J., Ferling, H., Mallow, U., Wintermayr, H., & Negele, R. D. (2004). Toxic effects of the non-steroidal anti-inflammatory drug diclofenac: Part I: histopathological alterations and bioaccumulation in rainbow trout. Aquatic Toxicology 68(2): 141-150.

Swan G, Naidoo V, Cuthbert R, Green RE, Pain DJ, et al. (2006). Removing the Threat of Diclofenac to Critically Endangered Asian Vultures. PLoS Biology 4: 396–402.

Ternes, T.A. (1998). Occurrence of drugs in German sewage treatment plants and rivers. Water Research 32: 3245–3260.

Ternes, T.A., Stuber, J., Herrmann, N., McDowell, D., Ried, A., Kampmann, M. & Teiser, B. (2003). Ozonation: A tool for removal of pharmaceuticals, contrast media and musk fragnances from wastewater. Water Research 37: 1976–1982.

Tixier C, Singer HP, Oellers S, Muller SR. (2003). Occurrence and fate of carbamazepine, clofibric acid, diclofenac, ibuprofen, ketoprofen, and naproxen in surface waters. Environ Sci Technol 37:1061–1068. doi:10.1021/es025834r

Triebskorn, R., Casper, H., Heyd, A., Eikemper, R., Köhler H-R. & Schwaiger, J. (2004). Toxic effects of non-steroidal anti-inflammatory drug diclofenac. Part II. Cytological effects on liver, kidney, gills, and intestine of rainbow trout (Oncorhynchus mykiss). Aquatic Toxicology 68: 151-66.

Turja, R., Höher, N., Snoeijs, P., Baršienė, J., Butrimavičienė, L., et al., (2014). A multibiomarker approach to the assessment of pollution impacts in two Baltic Sea coastal areas in Sweden using caged mussels (Mytilus trossulus). Science of the Total Environment 473: 398-409.

Turja, R., Lehtonen, K. K., Meierjohann, A., Brozinski, J. M., Vahtera, et al., (2015). The mussel caging approach in assessing biological effects of wastewater treatment plant discharges in the Gulf of Finland (Baltic Sea). Marine pollution bulletin, 97(1): 135-149.

UNESCO and HELCOM (2017). Pharmaceuticals in the aquatic environment of the Baltic Sea region – A status report. UNESCO Emerging Pollutants in Water Series 1 – No. 1, UNESCO Publishing, Paris.

Vieno, N. (2007). Occurrence of pharmaceuticals in Finnish sewage treatment plants, surface waters and their elimination in drinkin water processes. Doctoral thesis. Tampere University of Technology.

Vieno, N.M., Härkki, H., Tuhkanen, T. & Kronberg, L. (2007). Occurrence of pharmaceuticals in river waterand their elimination in a pilot-scale drinking water treatment plant.Enviro. Sci. Techno. 41:5077–5084.

Vieno, N. & Sillanpää, M. (2014). Fate of diclofenac in municipal wastewater treatment plan – A review. Environment International 69: 28-39.

Weber, F-A., aus der Beek, T., Bergmann, A., Carius, A., Gruttner, G., et al. (2014). Pharmaceuticals in the environment – the global perspective. Occurrence, effects, and potential cooperative action under SAICM. German Federal Ministry for the Environment, Nature Conservation, Building and nuclear Safety. Available at: https://www.umweltbundesamt.de/sites/default/files/medien/378/publikationen/pharmaceuticals_in_the_environment_0.pdf

Zhang, Y.; Geien S.; Gal, C. (2008). Carbamazepine and diclofenac - Removal in wastewater treatment plants and occurrence in water bodies. Chemosphere, 73, 1151–1161.

Zorita, S., Mårtensson, L., & Mathiasson L. (2009). Occurrence and removal of pharmaceuticals in a municipal sewage treatment system in the south of Sweden. Science of the Total Environment 407: 2760-70.

Zanuri, N. B. M., Bentley, M. G., & Caldwell, G. S. (2017). Assessing the impact of diclofenac, ibuprofen and sildenafil citrate (Viagra®) on the fertilisation biology of broadcast spawning marine invertebrates. Marine Environmental Research: 127, 126-136.

Äystö L., Mehtonen J., Kalevi K. 2014. Kartoitus lääkeaineista yhdyskuntajätevedessä ja pintavedessä. Loppuraportti 8.9.2014.

 

 

HELCOM pre-core indicator report
ISSN 2343-2543